Fortier Lisa A, Cole Brian J, McIlwraith C Wayne
Department of Clinical Science, Cornell University, Ithaca, New York 14853, USA.
J Knee Surg. 2012 Mar;25(1):3-8. doi: 10.1055/s-0032-1310389.
Microfracture of subchondral bone to enhance cartilage repair is a popular surgical technique used in human and animal patients. Clinical results with resolution or improvement in pain are promising and last on average for 2 to 3 years. Animal studies aimed at understanding microfracture indicate that the repair tissue continues to remodel toward chondrogenesis for at least a year, but longer term results are not available to gain insight into the mechanism of microfracture function or failure over time. Subchondral bone sclerosis and central lesional osteophyte formation following subchondral bone microfracture have been observed in animal models of microfracture, but studies do not provide any insight into the etiology of these pathologies. The continued maturation of microfracture repair tissue over time supports further investigation of microfracture or microfracture-augmented cartilage repair procedures with caution for the investigator and clinician to be observant for conditions that lead to subchondral bone sclerosis or central osteophyte formation, and what affect these boney reactions have on clinical outcome.
软骨下骨微骨折术用于促进软骨修复,是一种在人类和动物患者中广泛应用的外科技术。临床结果显示,疼痛缓解或改善效果良好,平均可持续2至3年。旨在了解微骨折术的动物研究表明,修复组织至少在一年内持续向软骨生成方向重塑,但长期结果尚未获得,无法深入了解微骨折术随时间推移的作用机制或失败原因。在微骨折术的动物模型中,已观察到软骨下骨微骨折术后软骨下骨硬化和中央病变骨赘形成,但研究并未对这些病变的病因提供任何见解。随着时间的推移,微骨折修复组织的持续成熟支持对微骨折术或微骨折增强软骨修复程序进行进一步研究,但研究人员和临床医生需谨慎观察导致软骨下骨硬化或中央骨赘形成的情况,以及这些骨反应对临床结果的影响。